HCC is a common type of cancer with increasing incidence. Intra-arterial therapies are often part of the treatment algorithm and several intra-arterial treatment options are available today, including C-TACE, DEB-TACE, balloon TACE, radiopaque DEB-TACE and TARE. This Clinical Procedure Training course gives experienced physicians the opportunity to fine-tune their practical skills and learn more about current treatment options for various stages of HCC and liver metastatic disease.
Theoretical presentations will be organised to allow participants to understand the staging and treatment algorithm of HCC and metastatic liver disease. Hands-on sessions will then provide the opportunity to handle current devices and to learn about the most advanced technologies fit for intra-arterial therapy. Due to the complexity of treating HCC and liver metastases, collaboration between medical oncologists, surgeons and radiation therapists is needed. A section of the programme will be dedicated to imaging follow-up and treatment evaluation. Highly experienced physicians will present complications and lessons learned.
We hope you can join us at the prestigious Hospital Barmherzige Brueder Munich for this exciting course!